SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-054254
Filing Date
2020-11-17
Accepted
2020-11-17 07:15:01
Documents
13
Period of Report
2020-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 11-20 alks-8k_20201117.htm   iXBRL 8-K 42475
2 EX-99.1 alks-ex991_15.htm EX-99.1 25744
  Complete submission text file 0001564590-20-054254.txt   204997

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20201117.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20201117_lab.xml EX-101.LAB 19413
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20201117_pre.xml EX-101.PRE 11606
6 EXTRACTED XBRL INSTANCE DOCUMENT alks-8k_20201117_htm.xml XML 3531
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 201319253
SIC: 2834 Pharmaceutical Preparations